Related Experiment Videos
Joint inflammation and cartilage destruction may occur uncoupled
1Department of Rheumatology, University Hospital Nijmegen, The Netherlands.
Springer Seminars in Immunopathology
|December 4, 1998
Summary
Chronic arthritis involves joint inflammation and destruction. While tumor necrosis factor (TNF) drives swelling, interleukin-1 (IL-1) is the primary driver of cartilage damage, often independent of TNF. Novel therapies should target both inflammation and destruction.
Area of Science:
- Rheumatology
- Immunology
- Orthopedics
Background:
- Chronic arthritis features persistent joint inflammation and destruction.
- Tumor necrosis factor (TNF) and interleukin-1 (IL-1) are key cytokines in rheumatoid arthritis (RA).
- Joint destruction can occur independently of overt inflammation.
Purpose of the Study:
- To investigate the distinct roles of TNF and IL-1 in arthritis-induced joint destruction.
- To explore the influence of regulatory cytokines and growth factors on cartilage damage.
- To evaluate the correlation between inflammation and destructive potential in arthritis models.
Main Methods:
- Utilized anti-TNF/IL-1 neutralizing antibodies in experimental arthritis models.
- Examined arthritis models in TNF and IL-1 knockout mice.
- Assessed the impact of regulatory cytokines (IL-4, IL-6, IL-10) and transforming growth factor-beta (TGF-beta) on joint pathology.
Main Results:
- IL-1 is the dominant cytokine driving cartilage destruction, potentially independent of TNF.
- Regulatory cytokines (IL-4, IL-6, IL-10) reduced cartilage destruction.
- Transforming growth factor-beta (TGF-beta) significantly reduced cartilage damage despite increasing synovitis.
Conclusions:
- Joint destruction in chronic arthritis is not always coupled to inflammation levels.
- Therapeutic strategies for RA should address both inflammation and cartilage destruction.
- Targeting IL-1 and leveraging anabolic factors like TGF-beta may be crucial for preventing joint damage.